Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management.

Sun M, Becker A, Tian Z, Roghmann F, Abdollah F, Larouche A, Karakiewicz PI, Trinh QD.

Eur Urol. 2014 Jan;65(1):235-41. doi: 10.1016/j.eururo.2013.03.034. Epub 2013 Mar 27.

PMID:
23567066
2.

A non-cancer-related survival benefit is associated with partial nephrectomy.

Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI.

Eur Urol. 2012 Apr;61(4):725-31. doi: 10.1016/j.eururo.2011.11.047. Epub 2011 Dec 3.

PMID:
22172373
3.

A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.

Bianchi M, Gandaglia G, Trinh QD, Hansen J, Becker A, Abdollah F, Tian Z, Lughezzani G, Roghmann F, Briganti A, Montorsi F, Karakiewicz PI, Sun M.

Urol Oncol. 2014 Jan;32(1):46.e1-7. doi: 10.1016/j.urolonc.2013.06.010. Epub 2013 Sep 17.

PMID:
24054864
4.

A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.

Crépel M, Jeldres C, Sun M, Lughezzani G, Isbarn H, Alasker A, Capitanio U, Shariat SF, Arjane P, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.

Urology. 2010 Oct;76(4):883-8. doi: 10.1016/j.urology.2009.08.028.

PMID:
20932408
5.

Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical management.

Patel HD, Kates M, Pierorazio PM, Hyams ES, Gorin MA, Ball MW, Bhayani SB, Hui X, Thompson CB, Allaf ME.

Urology. 2014 Jan;83(1):126-32. doi: 10.1016/j.urology.2013.08.088. Epub 2013 Nov 16.

6.

Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.

Sun M, Bianchi M, Trinh QD, Hansen J, Abdollah F, Hanna N, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI.

BJU Int. 2013 Jan;111(1):67-73. doi: 10.1111/j.1464-410X.2012.11254.x. Epub 2012 May 22.

7.

Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.

Zini L, Patard JJ, Capitanio U, Crepel M, de La Taille A, Tostain J, Ficarra V, Bernhard JC, Ferrière JM, Pfister C, Villers A, Montorsi F, Karakiewicz PI.

BJU Int. 2009 Apr;103(7):894-8. doi: 10.1111/j.1464-410X.2008.08252.x. Epub 2008 Dec 2.

8.

Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.

Kaushik D, Kim SP, Childs MA, Lohse CM, Costello BA, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.

Eur Urol. 2013 Oct;64(4):600-6. doi: 10.1016/j.eururo.2012.12.023. Epub 2012 Dec 25.

PMID:
23280319
9.

Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.

Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM.

BJU Int. 2012 May;109(10):1457-62. doi: 10.1111/j.1464-410X.2011.10597.x. Epub 2011 Sep 20.

10.

Overall survival advantage with partial nephrectomy: a bias of observational data?

Shuch B, Hanley J, Lai J, Vourganti S, Kim SP, Setodji CM, Dick AW, Chow WH, Saigal C; Urologic Diseases in America Project..

Cancer. 2013 Aug 15;119(16):2981-9. doi: 10.1002/cncr.28141. Epub 2013 May 14.

11.

Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life.

May M, Cindolo L, Zigeuner R, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Wolff I, Feciche B, Fenske F, Pichler M, Schips L, Figenshau RS, Madison K, Sánchez-Chapado M, Santiago Martin Mdel C, Salzano L, Lotrecchiano G, Waidelich R, Stief C, Sountoulides P, Brookman-May S; Members of CORONA project.; Young Academic Urologists Renal Cancer Group..

Urol Oncol. 2014 Nov;32(8):1252-8. doi: 10.1016/j.urolonc.2014.04.013. Epub 2014 Aug 14.

PMID:
25129141
12.

Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.

Sun M, Trinh QD, Bianchi M, Hansen J, Abdollah F, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI.

BJU Int. 2014 Jan;113(1):36-42. doi: 10.1111/j.1464-410X.2012.11693.x. Epub 2013 Mar 12.

13.

Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.

Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA.

Eur Urol. 2012 Jun;61(6):1156-61. doi: 10.1016/j.eururo.2012.01.001. Epub 2012 Jan 10.

PMID:
22257424
14.

Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.

O'Malley RL, Hayn MH, Brewer KA, Underwood W 3rd, Hellenthal NJ, Kim HL, Sorokin I, Schwaab T.

World J Urol. 2015 Nov;33(11):1807-14. doi: 10.1007/s00345-015-1538-z. Epub 2015 Mar 25.

PMID:
25805189
15.

Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.

Weight CJ, Kim SP, Lohse CM, Cheville JC, Thompson RH, Boorjian SA, Leibovich BC.

Eur Urol. 2011 Sep;60(3):458-64. doi: 10.1016/j.eururo.2011.04.022. Epub 2011 Apr 16.

PMID:
21514718
16.

Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.

Crépel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat SF, Liberman D, Sun M, Lughezzani G, Arjane P, Widmer H, Graefen M, Montorsi F, Patard JJ, Karakiewicz PI.

Urology. 2010 Feb;75(2):271-5. doi: 10.1016/j.urology.2009.04.098. Epub 2009 Dec 4.

PMID:
19962740
17.

Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).

Capitanio U, Perrotte P, Zini L, Jeldres C, Shariat SF, Isbarn H, Arjane P, Peloquin F, Pharand D, Montorsi F, Karakiewicz PI.

BJU Int. 2009 Sep;104(6):795-9. doi: 10.1111/j.1464-410X.2009.08484.x. Epub 2009 Apr 15.

18.

Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD).

Yap SA, Finelli A, Urbach DR, Tomlinson GA, Alibhai SM.

BJU Int. 2015 Jun;115(6):897-906. doi: 10.1111/bju.12883. Epub 2015 Feb 5.

19.
20.

Do we know (or just believe) that partial nephrectomy leads to better survival than radical nephrectomy for renal cancer?

Tobert CM, Riedinger CB, Lane BR.

World J Urol. 2014 Jun;32(3):573-9. doi: 10.1007/s00345-014-1275-8. Epub 2014 Mar 27. Review.

PMID:
24671608

Supplemental Content

Support Center